Any current/future new fundraising through debt or equity?

The company currently has no plans for any new fundraise via debt or equity. The existing debt is primarily working capital debt, which is short-term and expected to continue for the next couple of years unless internal accruals improve. Management indicated that they are not planning any additional equity or long-term debt fundraise currently. Working capital debt will persist to manage operational needs; no long-term debt repayment plan was specified beyond utilizing internal cash flows.

Any current/future capex/capital investment/strategic investment?

FY '26 capex target is INR 350 crores. Around INR 100-150 crores of capex will be invested in Site 5 (Panoli). Site 3++ (dedicated to Milliken) will see INR 200-250 crores capitalized this fiscal, expected to commence production by Q4 FY '26. Site 5 construction is on track; first two production blocks targeted for completion by end of Q3 FY '26. Capex cost per plant at Site 5 is approx. INR 160-180 crores with an expected asset turn of 1.75x at maturity. R&D expansion with an investment of INR 30-40 crores planned to increase number of labs and fume hoods. Multipurpose plant designs allow fle

Future growth expectations in earnings/operating earnings/profits/EPS?

Aether Industries expects strong growth driven by new projects and site expansions, notably Site 3++ (Milliken contract), Site-4 (Baker Hughes), and Site-5. The company is rapidly commercializing new molecules with a faster customer contract timeline (now 6 months to 1 year). EBITDA margins remain robust (~30%), and PAT rose 57% YoY in Q1 FY '26. Volume growth is strong across LSM, CEM, and CRAMS segments despite price pressure due to Chinese dumping. Capex of INR 300-350 crores in FY '26 will support capacity expansion and R&D, enabling growth. Working capital cycle reduction target to ~165 d

Current/ Expected Orderbook/ Pending Orders?

Aether Industries currently has approximately 12 to 18 projects with various customers, including Milliken, that are in advanced stages or near finalization. The negotiation cycle for contracts like Milliken has shortened significantly from earlier timelines of 1 to 1.5 years down to 4 to 6 months, indicating faster closure of new orders. The company is fast-tracking several new contracts and projects, including those at Site 3++, Site-4 (Baker Hughes), and Site-5, which are expected to contribute to revenue growth over the next 18 months. Capacity-wise, smaller orders (under 100-200 tons) can

IN US

Sale is live|00:00:00left today

Aether Industries LtdQ2 FY25Chemicals & Petrochemicals

Aether Industries Ltd Q2 FY25 Earnings Call Analysis

Q: Future growth expectations in sales/revenue/volumes?

Future Growth Expectations of Aether Industries Limited: Sales revenue grew 35% YoY in Q1 FY '26, indicating strong growth momentum. Large-Scale Manufacturing (LSM) segment growing at 9% YoY and 8% QoQ, with stable product prices and margins. Contract/Exclusive Manufacturing (CEM) business ramping up, notably Baker Hughes contract contributing significantly with revenues rising from INR25 crores in Q4 to INR41 crores in Q1. Site-5 capex of INR100-150 crores planned, expected to drive future volume and revenue growth with new plants coming online by end of calendar year. Milliken contract to b

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,325P/E: 65.2Market Cap: ₹14.7K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

Order

Yes

Capex

Yes

2 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 2

Future Growth Expectations of Aether Industries Limited: - Sales revenue grew 35% YoY in Q1 FY '26, indicating strong growth momentum. - Large-Scale Manufacturing (LSM) segment growing at 9% YoY and 8% QoQ, with stable product prices and margins. - Contract/Exclusive Manufacturing (CEM) business ramping up, notably Baker Hughes contract contributing significantly with revenues rising from INR25 crores in Q4 to INR41 crores in Q1. - Site-5 capex of INR100-150 crores planned, expected to drive future volume and revenue growth with new plants coming online by end of calendar year. - Milliken contract to be commercialized in FY '26 with expectations of good ramp-up in FY '27. - Pipeline includes 12-18 projects in advanced stages, likely to close within 4-6 months, supporting rapid growth. - Target to reduce working capital cycle to ~150-170 days by FY '27 to improve operational efficiency. - Overall bullish outlook driven by increased R&D projects, new client additions, and expansion in material science and sustainability sectors.

Margin guidance

Category 3

→Aether Industries expects strong growth driven by new projects and site expansions, notably Site 3++ (Milliken contract), Site-4 (Baker Hughes), and Site-5.
→The company is rapidly commercializing new molecules with a faster customer contract timeline (now 6 months to 1 year).
→EBITDA margins remain robust (~30%), and PAT rose 57% YoY in Q1 FY '26.
→Volume growth is strong across LSM, CEM, and CRAMS segments despite price pressure due to Chinese dumping.
→Capex of INR 300-350 crores in FY '26 will support capacity expansion and R&D, enabling growth.
→Working capital cycle reduction target to ~165 days aims for better operating efficiency.
→While no forward revenue/profit guidance given, management anticipates these new contracts and sites will be primary growth drivers in FY '26 and FY '27.
→Increasing customer wallet share with innovative, India-made specialty chemicals fuels long-term profitability.

3 more insights locked — sign up free to unlock

Fundraise plans

→The company currently has no plans for any new fundraise via debt or equity.
→The existing debt is primarily working capital debt, which is short-term and expected to continue for the next couple of years unless internal accruals improve.
→Management indicated that they are not planning any additional equity or long-term debt fundraise currently.
→Working capital debt will persist to manage operational needs; no long-term debt repayment plan was specified beyond utilizing internal cash flows.

Order book

Yes

→Aether Industries currently has approximately 12 to 18 projects with various customers, including Milliken, that are in advanced stages or near finalization.
→The negotiation cycle for contracts like Milliken has shortened significantly from earlier timelines of 1 to 1.5 years down to 4 to 6 months, indicating faster closure of new orders.
→The company is fast-tracking several new contracts and projects, including those at Site 3++, Site-4 (Baker Hughes), and Site-5, which are expected to contribute to revenue growth over the next 18 months.
→Capacity-wise, smaller orders (under 100-200 tons) can be accommodated in existing sites (Site-2, Site-3), while larger bulk contracts (200-500+ tons) will be handled at Site-5.
→The company continues to add new clients, with six new clients added in Q1 FY '26, indicating a healthy pipeline of pending orders and new business opportunities.

Capex plans

Yes

→FY '26 capex target is INR 350 crores.
→Around INR 100-150 crores of capex will be invested in Site 5 (Panoli).
→Site 3++ (dedicated to Milliken) will see INR 200-250 crores capitalized this fiscal, expected to commence production by Q4 FY '26.
→Site 5 construction is on track; first two production blocks targeted for completion by end of Q3 FY '26.
→Capex cost per plant at Site 5 is approx. INR 160-180 crores with an expected asset turn of 1.75x at maturity.
→R&D expansion with an investment of INR 30-40 crores planned to increase number of labs and fume hoods.
→Multipurpose plant designs allow flexibility with minimal capex (~less than INR 50 lakh) to switch chemistries.
→Future projects and ramp-up at Sites 3++, 4 (Baker Hughes), and 5 are strategic growth drivers.

How does Aether Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Aether Industries Ltd

Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Aether Industries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio